KLHL40-Related Myopathy: A Systematic Review and Insight into a Follow-up Biomarker via a New Case Report

Background: Mutations in the <i>KLHL40</i> gene are a common cause of severe or even lethal nemaline myopathy. Some cases with mild forms have been described, although the cases are still anecdotal. The aim of this paper was to systematically review the cases described in the literature...

Full description

Bibliographic Details
Main Authors: Bianca Buchignani, Gemma Marinella, Rosa Pasquariello, Giada Sgherri, Silvia Frosini, Filippo Maria Santorelli, Alessandro Orsini, Roberta Battini, Guja Astrea
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/15/2/208
_version_ 1797298123304861696
author Bianca Buchignani
Gemma Marinella
Rosa Pasquariello
Giada Sgherri
Silvia Frosini
Filippo Maria Santorelli
Alessandro Orsini
Roberta Battini
Guja Astrea
author_facet Bianca Buchignani
Gemma Marinella
Rosa Pasquariello
Giada Sgherri
Silvia Frosini
Filippo Maria Santorelli
Alessandro Orsini
Roberta Battini
Guja Astrea
author_sort Bianca Buchignani
collection DOAJ
description Background: Mutations in the <i>KLHL40</i> gene are a common cause of severe or even lethal nemaline myopathy. Some cases with mild forms have been described, although the cases are still anecdotal. The aim of this paper was to systematically review the cases described in the literature and to describe a 12-year clinical and imaging follow-up in an Italian patient with KLHL40- related myopathy in order to suggest possible follow-up measurements. Methods: Having searched through three electronic databases (PubMed, Scopus, and EBSCO), 18 articles describing 65 patients with homozygous or compound heterozygous <i>KLHL40</i> mutations were selected. A patient with a <i>KLHL40</i> homozygous mutation (c.1582G>A/p.E528K) was added and clinical and genetic data were collected. Results: The most common mutation identified in our systematic review was the (c.1516A>C) followed by the (c.1582G>A). In our review, 60% percent of the patients died within the first 4 years of life. Clinical features were similar across the sample. Unfortunately, however, there is no record of the natural history data in the surviving patients. The 12-year follow-up of our patient revealed a slow improvement in her clinical course, identifying muscle MRI as the only possible marker of disease progression. Conclusions: Due to its clinical and genotype homogeneity, KLHL40-related myopathy may be a condition that would greatly benefit from the development of new gene therapies; muscle MRI could be a good biomarker to monitor disease progression.
first_indexed 2024-03-07T22:31:18Z
format Article
id doaj.art-17ea6281808a49b9967ea9fbaabf54df
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-07T22:31:18Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-17ea6281808a49b9967ea9fbaabf54df2024-02-23T15:17:50ZengMDPI AGGenes2073-44252024-02-0115220810.3390/genes15020208KLHL40-Related Myopathy: A Systematic Review and Insight into a Follow-up Biomarker via a New Case ReportBianca Buchignani0Gemma Marinella1Rosa Pasquariello2Giada Sgherri3Silvia Frosini4Filippo Maria Santorelli5Alessandro Orsini6Roberta Battini7Guja Astrea8Department of Neuroscience, IRCCS Stella Maris Foundation, 56128 Pisa, ItalyDepartment of Neuroscience, IRCCS Stella Maris Foundation, 56128 Pisa, ItalyDepartment of Neuroscience, IRCCS Stella Maris Foundation, 56128 Pisa, ItalyDepartment of Neuroscience, IRCCS Stella Maris Foundation, 56128 Pisa, ItalyDepartment of Neuroscience, IRCCS Stella Maris Foundation, 56128 Pisa, ItalyMolecular Medicine and Neurogenetics Unit, IRCCS Stella Maris Foundation, 56128 Pisa, ItalyPediatric Neurology, Azienda Ospedaliera Universitaria Pisana, 56100 Pisa, ItalyDepartment of Neuroscience, IRCCS Stella Maris Foundation, 56128 Pisa, ItalyDepartment of Neuroscience, IRCCS Stella Maris Foundation, 56128 Pisa, ItalyBackground: Mutations in the <i>KLHL40</i> gene are a common cause of severe or even lethal nemaline myopathy. Some cases with mild forms have been described, although the cases are still anecdotal. The aim of this paper was to systematically review the cases described in the literature and to describe a 12-year clinical and imaging follow-up in an Italian patient with KLHL40- related myopathy in order to suggest possible follow-up measurements. Methods: Having searched through three electronic databases (PubMed, Scopus, and EBSCO), 18 articles describing 65 patients with homozygous or compound heterozygous <i>KLHL40</i> mutations were selected. A patient with a <i>KLHL40</i> homozygous mutation (c.1582G>A/p.E528K) was added and clinical and genetic data were collected. Results: The most common mutation identified in our systematic review was the (c.1516A>C) followed by the (c.1582G>A). In our review, 60% percent of the patients died within the first 4 years of life. Clinical features were similar across the sample. Unfortunately, however, there is no record of the natural history data in the surviving patients. The 12-year follow-up of our patient revealed a slow improvement in her clinical course, identifying muscle MRI as the only possible marker of disease progression. Conclusions: Due to its clinical and genotype homogeneity, KLHL40-related myopathy may be a condition that would greatly benefit from the development of new gene therapies; muscle MRI could be a good biomarker to monitor disease progression.https://www.mdpi.com/2073-4425/15/2/208congenital myopathy<i>KLHL40</i>nemaline myopathiesKLHL40-related myopathy
spellingShingle Bianca Buchignani
Gemma Marinella
Rosa Pasquariello
Giada Sgherri
Silvia Frosini
Filippo Maria Santorelli
Alessandro Orsini
Roberta Battini
Guja Astrea
KLHL40-Related Myopathy: A Systematic Review and Insight into a Follow-up Biomarker via a New Case Report
Genes
congenital myopathy
<i>KLHL40</i>
nemaline myopathies
KLHL40-related myopathy
title KLHL40-Related Myopathy: A Systematic Review and Insight into a Follow-up Biomarker via a New Case Report
title_full KLHL40-Related Myopathy: A Systematic Review and Insight into a Follow-up Biomarker via a New Case Report
title_fullStr KLHL40-Related Myopathy: A Systematic Review and Insight into a Follow-up Biomarker via a New Case Report
title_full_unstemmed KLHL40-Related Myopathy: A Systematic Review and Insight into a Follow-up Biomarker via a New Case Report
title_short KLHL40-Related Myopathy: A Systematic Review and Insight into a Follow-up Biomarker via a New Case Report
title_sort klhl40 related myopathy a systematic review and insight into a follow up biomarker via a new case report
topic congenital myopathy
<i>KLHL40</i>
nemaline myopathies
KLHL40-related myopathy
url https://www.mdpi.com/2073-4425/15/2/208
work_keys_str_mv AT biancabuchignani klhl40relatedmyopathyasystematicreviewandinsightintoafollowupbiomarkerviaanewcasereport
AT gemmamarinella klhl40relatedmyopathyasystematicreviewandinsightintoafollowupbiomarkerviaanewcasereport
AT rosapasquariello klhl40relatedmyopathyasystematicreviewandinsightintoafollowupbiomarkerviaanewcasereport
AT giadasgherri klhl40relatedmyopathyasystematicreviewandinsightintoafollowupbiomarkerviaanewcasereport
AT silviafrosini klhl40relatedmyopathyasystematicreviewandinsightintoafollowupbiomarkerviaanewcasereport
AT filippomariasantorelli klhl40relatedmyopathyasystematicreviewandinsightintoafollowupbiomarkerviaanewcasereport
AT alessandroorsini klhl40relatedmyopathyasystematicreviewandinsightintoafollowupbiomarkerviaanewcasereport
AT robertabattini klhl40relatedmyopathyasystematicreviewandinsightintoafollowupbiomarkerviaanewcasereport
AT gujaastrea klhl40relatedmyopathyasystematicreviewandinsightintoafollowupbiomarkerviaanewcasereport